Clinical Trial Update: A Long-term Trial of EB-1020 in Adult Patients With ADHD [Phase 3]

View source ↗

Summary

A long-term Phase 3 trial of EB-1020 in adults with ADHD is currently recruiting. The sponsor listed is Otsuka Pharmaceutical Co., Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• EB-1020

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Attention Deficit Hyperactivity Disorder (ADHD) | Phase 3 | Status: RECRUITING